Forbes September 16, 2021
Russell Flannery

Prenetics Group, a Hong Kong-based genomic and diagnostic testing firm, and Artisan Acquisition, a Nasdaq-listed SPAC founded by businessman Adrian Cheng, on Wednesday announced a merger agreement that would value Prenetics at $1.2 billion.

The transaction would make Prenetics the first unicorn from Hong Kong to be publicly listed in any market, according to a Prenetics press release.  

Prenetics, whose investors include Alibaba Group, will receive up to $459 million in cash, including up to $339 million of cash currently held in Artisan’s trust account, and $120 million through purchase agreements from Aspex, PAG, Lippo, Dragonstone, Xen Capital and others, along with...

Today's Sponsors


Today's Sponsors

Crossover Health

Today's Sponsor

Institute for Healthcare Improvement

Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma / Biotech, Trends
Better Medicare Alliance: MA adds $32.5B in value to Medicare
Oak Street Health Acquires Telehealth Company RubiconMD for $130 Million
Ascension, AdventHealth unwind joint venture Amita Health in Chicago
6 recent pharmaceutical deals, acquisitions
How PE Is Pushing Behavioral Health M&A to New Dealmaking Heights